The AstraZeneca’s US Primary Care - Respiratory and Immunology (R&I) Team holds a unique position in respiratory disease, including asthma, chronic obstructive pulmonary disease (COPD) and Lupus, with a range of differentiated potential medicines in development.
Base: $175,000–$230,000 USD Annual; Bonus/Equity: Short-term incentive bonus opportunity, equity-based long-term incentive program; Benefits: 401(k) plan, paid vacation and holidays, paid leaves, health benefits
Must-have
Nice-to-have
Not specified